Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313363672> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4313363672 endingPage "11" @default.
- W4313363672 startingPage "5" @default.
- W4313363672 abstract "Non‑alcoholic fatty liver disease (NAFLD) remains the leading nosology among hepatic diseases around the world. Its complex pathogenesis is not still clearly understood. Besides metabolic changes one of potential mechanisms of NAFLD development is changes in hepatokines, fetuin‑A in particular, secretion and metabolism.
 Objective — to determine the role of fetuin‑A in the development and progression of NAFLD.
 Materials and methods. The study enrolled 78 NAFLD patients with metabolic disorders and 30 volunteers as a control group. Additionally to routine examination serum concentration of fetuin‑A was determined. Statistical processing was carried out using SPSS 21.
 Results. The results showed a statistically significant increase in fetuin‑A concentrations in NAFLD patients with concomitant MS (p < 0.05). There was a direct correlation between fetuin‑A levels and parameters of abdominal (WC and WHR, p < 0.05) and visceral obesity (VAT %, p < 0.05). Concentrations of fetuin‑A were higher in polymorbid patients, especially in the combination of NAFLD with type 2 diabetes mellitus and obesity. Fetuin‑A levels was associated with changes in carbohydrates and lipids parameters. Fetuin‑A positively correlated with glycated hemoglobin (r = 0.32, p < 0.05) and index HOMA (r = 0.36, p < 0.05). There was a positive correlation between fetuin‑A level and TG (r = 0.44, p < 0.05) and LDL cholesterol (r = 0.37, p < 0.05). Furthermore, an increase in fetuin‑A was associated with an increase in activity of ALT (r = 0.39, p < 0.05) and elevation of the level of TNF‑a (r = 0.33, p < 0.05). NAFLD patients with advanced stages of steatosis and fibrosis also demonstrated higher levels of fetuin‑A (p < 0.05).
 Conclusions. The obtained data indicate a significant pathogenetic role of fetuin‑A in the development and progression of NAFLD.
" @default.
- W4313363672 created "2023-01-06" @default.
- W4313363672 creator A5021226498 @default.
- W4313363672 creator A5031565806 @default.
- W4313363672 creator A5061893774 @default.
- W4313363672 creator A5065826467 @default.
- W4313363672 creator A5080817422 @default.
- W4313363672 creator A5082889379 @default.
- W4313363672 date "2022-12-29" @default.
- W4313363672 modified "2023-10-14" @default.
- W4313363672 title "Pathogenetic role of fetuin-A in formation of metabolic disorders and systemic inflammation in patients with non-alcoholic fatty liver disease" @default.
- W4313363672 doi "https://doi.org/10.30978/mg-2022-5-5" @default.
- W4313363672 hasPublicationYear "2022" @default.
- W4313363672 type Work @default.
- W4313363672 citedByCount "0" @default.
- W4313363672 crossrefType "journal-article" @default.
- W4313363672 hasAuthorship W4313363672A5021226498 @default.
- W4313363672 hasAuthorship W4313363672A5031565806 @default.
- W4313363672 hasAuthorship W4313363672A5061893774 @default.
- W4313363672 hasAuthorship W4313363672A5065826467 @default.
- W4313363672 hasAuthorship W4313363672A5080817422 @default.
- W4313363672 hasAuthorship W4313363672A5082889379 @default.
- W4313363672 hasBestOaLocation W43133636721 @default.
- W4313363672 hasConcept C108625454 @default.
- W4313363672 hasConcept C126322002 @default.
- W4313363672 hasConcept C134018914 @default.
- W4313363672 hasConcept C2777180221 @default.
- W4313363672 hasConcept C2777538456 @default.
- W4313363672 hasConcept C2777693730 @default.
- W4313363672 hasConcept C2778541144 @default.
- W4313363672 hasConcept C2778772119 @default.
- W4313363672 hasConcept C2779134260 @default.
- W4313363672 hasConcept C2779478299 @default.
- W4313363672 hasConcept C2780578515 @default.
- W4313363672 hasConcept C2780942790 @default.
- W4313363672 hasConcept C511355011 @default.
- W4313363672 hasConcept C55493867 @default.
- W4313363672 hasConcept C555293320 @default.
- W4313363672 hasConcept C71924100 @default.
- W4313363672 hasConcept C86803240 @default.
- W4313363672 hasConcept C90924648 @default.
- W4313363672 hasConceptScore W4313363672C108625454 @default.
- W4313363672 hasConceptScore W4313363672C126322002 @default.
- W4313363672 hasConceptScore W4313363672C134018914 @default.
- W4313363672 hasConceptScore W4313363672C2777180221 @default.
- W4313363672 hasConceptScore W4313363672C2777538456 @default.
- W4313363672 hasConceptScore W4313363672C2777693730 @default.
- W4313363672 hasConceptScore W4313363672C2778541144 @default.
- W4313363672 hasConceptScore W4313363672C2778772119 @default.
- W4313363672 hasConceptScore W4313363672C2779134260 @default.
- W4313363672 hasConceptScore W4313363672C2779478299 @default.
- W4313363672 hasConceptScore W4313363672C2780578515 @default.
- W4313363672 hasConceptScore W4313363672C2780942790 @default.
- W4313363672 hasConceptScore W4313363672C511355011 @default.
- W4313363672 hasConceptScore W4313363672C55493867 @default.
- W4313363672 hasConceptScore W4313363672C555293320 @default.
- W4313363672 hasConceptScore W4313363672C71924100 @default.
- W4313363672 hasConceptScore W4313363672C86803240 @default.
- W4313363672 hasConceptScore W4313363672C90924648 @default.
- W4313363672 hasIssue "5—6" @default.
- W4313363672 hasLocation W43133636721 @default.
- W4313363672 hasOpenAccess W4313363672 @default.
- W4313363672 hasPrimaryLocation W43133636721 @default.
- W4313363672 hasRelatedWork W172874805 @default.
- W4313363672 hasRelatedWork W2037332452 @default.
- W4313363672 hasRelatedWork W2073915513 @default.
- W4313363672 hasRelatedWork W2087665565 @default.
- W4313363672 hasRelatedWork W2110205672 @default.
- W4313363672 hasRelatedWork W2278593945 @default.
- W4313363672 hasRelatedWork W2361160695 @default.
- W4313363672 hasRelatedWork W2409817955 @default.
- W4313363672 hasRelatedWork W2561118033 @default.
- W4313363672 hasRelatedWork W2747007034 @default.
- W4313363672 isParatext "false" @default.
- W4313363672 isRetracted "false" @default.
- W4313363672 workType "article" @default.